Yang YS, Ren YX, Liu CL, Hao S, et al. The early-stage triple-negative breast cancer landscape derives a novel prognostic signature and therapeutic target. Breast Cancer Res Treat 2022 Mar 25. pii: 10.1007/s10549-022-06537.
PMID: 35334008